Migraine Relief

Product NDC
83324-099
11-digit product format
833240099
Labeler code
83324
Product ID
83324-099_1ac6eaf4-0946-732a-e063-6394a90a303d
Type
HUMAN OTC DRUG
Nonproprietary name
ACETAMINOPHEN, ASPIRIN and CAFFEINE
Dosage form
TABLET
Route
ORAL
Labeler
CHAIN DRUG MARKETING ASSOCIATION, INC.
Application
ANDA214039
Marketing category
ANDA
Marketing start
2024-05-01
Substance
ACETAMINOPHEN; ASPIRIN; CAFFEINE
Active strength
250; 250; 65 mg/1; mg/1; mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
362O9ITL9DACETAMINOPHEN103-90-2ACETAMINOPHEN
R16CO5Y76EASPIRIN50-78-2ASPIRIN
3G6A5W338ECAFFEINE58-08-2CAFFEINE

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
83324-099-24833240099241 BOTTLE, PLASTIC in 1 CARTON (83324-099-24) / 24 TABLET in 1 BOTTLE, PLASTIC2024-05-01NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
1205-QCH-2024-0613CHAIN DRUG MARKETING ASSOCIATION, INC.2024-06-13HUMAN OTC DRUG LABEL2